Electronic screening of medical records to detect inpatients at risk of drug-related problems

Abstract

This tool allows for efficient and rapid screening of patients at risk of DRPs in preparation for the ward round. It helps CPs to prioritize their medication reviews and to optimize their workload.

Design of a score to identify hospitalized patients at risk of drug‐related problems

“…The percentage of in‐hospital patients experiencing a DRP in our study was similar to that reported by other authors who identified 33 DRP per 100 in‐hospital patients, with a mean of 1.71 DRP per patient in those with DRP . Much higher figures for DRP have been reported, ranging between 64.7% and 81.3%, although these figures are drawn from analyses of a small number of medical departments and included patients with comorbidities that could explain these values. In these studies, the rate of DRP per patient was between 3.17 and 6.5 .…”

“…Computerized physician order entry (CPOE) systems have recently become available, and their application in the daily monitoring of the drug therapy of in-hospital patients can help to detect DRP and identify their possible causes. 12,13 Certain clinical and/or demographic characteristics, nevertheless, can increase the risk of DRP in some hospitalized patients, requiring closer monitoring of pharmacological therapy. Consequently, the aim of this study was to design a risk score to identify DRP-prone in-hospital patients.…”

Prescription patterns for diabetes mellitus and therapeutic implications: a population-based analysis

“…Thus, it may possible to describe drug use patterns, analyze early signals of the irrational drug use, promote interventions to improve drug use, analyze quality control cycles, and promote continuous quality improvement (4)(5)(6)(7).…”

High‐risk medicines associated with clinically relevant medication‐related problems in UK hospitals: A prospective observational study

“…Previous research has identified medicines that are potentially high‐risk when used in a hospital inpatient setting, but no statistical assessment of high‐risk medicines and clinically relevant medication‐related problems (MRPs) has yet been conducted. Statistical assessment has potential to quantify the impact of groups of high‐risk medicines on the risk of developing clinically relevant MRPs, and to explore potential correlation between high‐risk medicines and other risk factors such as age and renal function.…”